The store will not work correctly when cookies are disabled.
(R)-gamma-(2-bromobenzyl)-L-proline Hydrochloride
ID: ALA4060165
Cas Number: 1049733-97-2
PubChem CID: 2761982
Max Phase: Preclinical
Molecular Formula: C12H15BrClNO2
Molecular Weight: 284.15
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.O=C(O)[C@@H]1C[C@@H](Cc2ccccc2Br)CN1
Standard InChI: InChI=1S/C12H14BrNO2.ClH/c13-10-4-2-1-3-9(10)5-8-6-11(12(15)16)14-7-8;/h1-4,8,11,14H,5-7H2,(H,15,16);1H/t8-,11+;/m1./s1
Standard InChI Key: FSCTVRPHDYFEBA-NINOIYOQSA-N
Molfile:
RDKit 2D
17 17 0 0 0 0 0 0 0 0999 V2000
13.5915 -6.3690 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.7920 -6.4003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6171 -6.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8739 -5.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2046 -5.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5395 -5.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2033 -4.3043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9172 -3.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6292 -4.3036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3426 -3.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3417 -3.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6216 -2.6535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9112 -3.0687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1013 -7.0682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7648 -7.8216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9219 -6.9830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1941 -2.6609 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
5 7 1 6
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
3 14 1 1
14 15 1 0
14 16 2 0
13 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.15 | Molecular Weight (Monoisotopic): 283.0208 | AlogP: 2.05 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.33 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.09 | CX Basic pKa: 11.45 | CX LogP: 0.14 | CX LogD: 0.14 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.89 | Np Likeness Score: 0.32 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |
2. Singh K, Tanui R, Gameiro A, Eisenberg G, Colas C, Schlessinger A, Grewer C.. (2017) Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2., 27 (3): [PMID:28057420] [10.1016/j.bmcl.2016.12.063] |